| # | Drug | Count |
|---|---|---|
| 0 | PREDNISOLONE | 31 |
| 1 | PREDNISOLONE ORAL | 31 |
| 2 | PREDNISOLONE ORAL SOLUTION | 31 |
| 3 | TACROLIMUS | 31 |
| 4 | PREDNISONE | 30 |
| 5 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 29 |
| 6 | TACROLIMUS OINTMENT 0.1% | 29 |
| 7 | METHOTREXATE SODIUM | 25 |
| 8 | MYCOPHENOLATE MOFETIL | 25 |
| 9 | METHOTREXATE | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DORAVIRINE | 1 | 0.0013 |
| 1 | DEFLAZACORT | 3 | 0.0012 |
| 2 | CHLOROTHIAZIDE SODIUM | 1 | 0.0011 |
| 3 | FOSCARNET SODIUM | 4 | 0.0010 |
| 4 | ALEMTUZUMAB | 18 | 0.0009 |
| 5 | RIFAMPICIN | 9 | 0.0009 |
| 6 | CHLOROTHIAZIDE | 1 | 0.0008 |
| 7 | INTERFERON GAMMA-1B | 1 | 0.0007 |
| 8 | ISONIAZID | 11 | 0.0007 |
| 9 | DUTASTERIDE | 5 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 70 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 29 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 22 |
| 3 | Alkylating Drug [EPC] | 19 |
| 4 | CD52-directed Cytolytic Antibody [EPC] | 18 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 16 |
| 6 | Purine Antimetabolite [EPC] | 13 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 12 |
| 8 | Antimycobacterial [EPC] | 11 |
| 9 | Macrolide Antimicrobial [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 18 | 0.0009 |
| 1 | Interferon gamma [EPC] | 1 | 0.0007 |
| 2 | Antimycobacterial [EPC] | 11 | 0.0005 |
| 3 | Rifamycin Antimycobacterial [EPC] | 1 | 0.0003 |
| 4 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0002 |
| 5 | Rifamycin Antibacterial [EPC] | 9 | 0.0002 |
| 6 | Echinocandin Antifungal [EPC] | 2 | 0.0002 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 3 | 0.0002 |
| 8 | Macrolide Antimicrobial [EPC] | 11 | 0.0002 |
| 9 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 4 | 0.0002 |